Macquarie Group »

Lyell Immunopharma shares owned by Macquarie Group

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Macquarie Group from 13F filings

Historical chart of Macquarie Group investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Macquarie Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Macquarie Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $731 505 1.45

More positions owned by Macquarie Group

Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Sap Se Spon Adr (SAP)
Veeva Sys Cl A Com (VEEV)
Waste Connections (WCN)
Hubspot (HUBS)
Ishares Tr Core Msci Eafe (IEFA)
Workiva Com Cl A (WK)
Kite Rlty Group Tr Com New (KRG)
Old National Ban (ONB)
MercadoLibre (MELI)
Datadog Cl A Com (DDOG)
The Trade Desk Com Cl A (TTD)
Dimensional Etf Trust Internatnal Val (DFIV)
Alibaba Group Hldg Sponsored Ads (BABA)

View all positions for Macquarie Group

Top funds holding Lyell Immunopharma

MWG Management
Orland Properties
BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
venBio Partners
T. Rowe Price Associates
Alphabet
Geode Capital Management
Citadel Advisors
State Street Corporation
OrbiMed Advisors
Sc China Holding
MIC Capital Management UK

View all funds holding Lyell Immunopharma